VeriMom¿Es chymotrypsin seguro durante el embarazo?
No harmonised CLP reproductive classification or SCCS/CIR safety assessment was found for chymotrypsin (CAS 9004-07-3), and I found no peer-reviewed reports of developmental or reproductive toxicity from topical exposure. Available regulatory records describe it as an enzyme/protease (use as food enzyme or laboratory reagent) and list respiratory/irritant hazards in some notifications (typical for enzymes) but not reproductive hazards. Sources: ECHA substance/registration pages and EFSA food-enzyme safety review; no CIR/SCCS or harmonised reproductive flags were identified.
Related ingredients
Frequently asked questions
- ¿Es chymotrypsin seguro durante el embarazo?
- No harmonised CLP reproductive classification or SCCS/CIR safety assessment was found for chymotrypsin (CAS 9004-07-3), and I found no peer-reviewed reports of developmental or reproductive toxicity from topical exposure. Available regulatory records describe it as an enzyme/protease (use as food enzyme or laboratory reagent) and list respiratory/irritant hazards in some notifications (typical for enzymes) but not reproductive hazards. Sources: ECHA substance/registration pages and EFSA food-enzyme safety review; no CIR/SCCS or harmonised reproductive flags were identified.
- ¿Es chymotrypsin seguro durante la lactancia?
- No data indicate chymotrypsin is a breastmilk-borne developmental hazard or that topical cosmetic use leads to systemic levels affecting lactation or the nursing infant. Human milk contains endogenous protease inhibitors (including antichymotrypsin), and regulatory reviews (food-enzyme safety) do not report lactation/transfer concerns. Respiratory sensitisation is noted in safety data sheets but does not constitute reproductive/lactation hazard evidence.
- ¿Es chymotrypsin seguro para la piel del bebé?
- There is no evidence of infant-specific reproductive toxicity. As a protein enzyme, chymotrypsin is a large molecule with very limited dermal bioavailability for intact skin, so adult exposure score is 0; however, by your scoring rules infant skin exposure is increased by +1 because baby skin has a less mature barrier and higher surface-area-to-weight, so baby e = 1. No studies show adverse developmental effects from topical cosmetic use in infants.
- ¿Cómo puntúa VeriMom a chymotrypsin?
- VeriMom puntúa chymotrypsin en 100/100 (sin riesgos conocidos) según el estado EU CosIng, clasificaciones ECHA y estudios PubMed.
- ¿Cuáles son las alternativas seguras a chymotrypsin en el embarazo?
- Consulta nuestra lista de alternativas seguras a chymotrypsin según función similar y clasificación sin riesgos conocidos.
Comprueba cualquier etiqueta en 2 segundos
Descarga VeriMom gratis — escanea cualquier producto y ve la puntuación de seguridad en el embarazo al instante.
Aviso Médico
Esta información es solo para fines educativos y no constituye asesoramiento médico. Las puntuaciones de seguridad se basan en datos disponibles públicamente y pueden no reflejar todos los riesgos. Siempre consulte a su profesional de salud antes de usar cualquier producto durante el embarazo o la lactancia.